A randomized placebo-controlled lovastatin trial for neurobehavioral function in neurofibromatosis I
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A randomized placebo-controlled lovastatin trial for neurobehavioral function in neurofibromatosis I
Authors
Keywords
-
Journal
Annals of Clinical and Translational Neurology
Volume 3, Issue 4, Pages 266-279
Publisher
Wiley
Online
2016-02-25
DOI
10.1002/acn3.288
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial
- (2014) Jeremy Chataway et al. LANCET
- Disrupted working memory circuitry and psychotic symptoms in 22q11.2 deletion syndrome
- (2014) C.A. Montojo et al. NeuroImage-Clinical
- Lovastatin improves impaired synaptic plasticity and phasic alertness in patients with neurofibromatosis type 1
- (2013) Florian Mainberger et al. BMC Neurology
- Autism traits in the RASopathies
- (2013) Brigid Adviento et al. JOURNAL OF MEDICAL GENETICS
- Challenges of cognitive research in neurofibromatosis type 1
- (2013) Maria T Acosta LANCET NEUROLOGY
- Simvastatin for cognitive deficits and behavioural problems in patients with neurofibromatosis type 1 (NF1-SIMCODA): a randomised, placebo-controlled trial
- (2013) Thijs van der Vaart et al. LANCET NEUROLOGY
- Power failure: why small sample size undermines the reliability of neuroscience
- (2013) Katherine S. Button et al. NATURE REVIEWS NEUROSCIENCE
- Autism and other psychiatric comorbidity in neurofibromatosis type 1: evidence from a population-based study
- (2012) SHRUTI GARG et al. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
- Impact of ADHD in Adults With Neurofibromatosis Type 1
- (2012) Victor-Felix Mautner et al. Journal of Attention Disorders
- Lovastatin regulates brain spontaneous low-frequency brain activity in Neurofibromatosis type 1
- (2012) Camille Chabernaud et al. NEUROSCIENCE LETTERS
- Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia II: Developing Imaging Biomarkers to Enhance Treatment Development for Schizophrenia and Related Disorders
- (2011) Cameron S. Carter et al. BIOLOGICAL PSYCHIATRY
- Lovastatin as Treatment for Neurocognitive Deficits in Neurofibromatosis Type 1: Phase I Study
- (2011) Maria T. Acosta et al. PEDIATRIC NEUROLOGY
- Birth incidence and prevalence of tumor-prone syndromes: Estimates from a UK family genetic register service
- (2010) D.G. Evans et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Neurofibromin regulates corticostriatal inhibitory networks during working memory performance
- (2010) C. Shilyansky et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neurofibromin Regulation of ERK Signaling Modulates GABA Release and Learning
- (2008) Yijun Cui et al. CELL
- Effect of Simvastatin on Cognitive Functioning in Children With Neurofibromatosis Type 1
- (2008) Lianne C. Krab JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Oncogenes on my mind: ERK and MTOR signaling in cognitive diseases
- (2008) Lianne C. Krab et al. TRENDS IN GENETICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started